Colgate-Palmolive Co stock (US1845021021): CL trades near recent highs as S&P 500 consumer staple consolidates

Colgate-Palmolive Co shares on the NYSE most recently changed hands around USD 90, consolidating strong year-to-date gains as investors weigh the latest first-quarter earnings and broader U.S. consumer staples sentiment.

Colgate-Palmolive Co shares on the New York Stock Exchange recently traded at about USD 90, close to their late-May 2026 levels, as the U.S. consumer staples heavyweight continued to consolidate year-to-date gains following its latest quarterly report, according to MarketBeat data as of 05/29/2026.

The stock, which is part of the U.S. household and personal care segment, closed at USD 90.26 on the NYSE on 05/29/2026, down 1.53% for that session but still significantly above where it started 2026, according to MarketBeat as of 05/29/2026. MarketBeat data show that CL began 2026 at about USD 79.02, implying a gain of roughly 14.2% year-to-date as of late May 2026.

In the broader context of U.S.-listed household names, Simply Wall St data as of late May 2026 show Colgate-Palmolive changing hands around USD 90.13, putting it among the largest U.S. household stocks by market capitalization and underscoring its role as a key S&P 500 consumer staples component.

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Colgate-Palmolive Co
• Sector/industry: Consumer staples - household and personal care products
• Headquarters/country: New York, United States
• Core markets: North America, Latin America, Europe, Asia-Pacific
• Key revenue drivers: Oral care, personal care, home care and pet nutrition brands
• Home exchange/listing venue: New York Stock Exchange (CL)
• Trading currency: USD

Colgate-Palmolive Co: core business model

Colgate-Palmolive Co focuses on branded oral care, personal care, home care and pet nutrition products, with sales driven mainly by its global Colgate, Palmolive and Hill's lines across developed and emerging markets.

What banks and research houses say about Colgate-Palmolive Co

For the Monday module, available aggregator data rather than named U.S. bank notes provide the clearest snapshot of current sentiment on Colgate-Palmolive Co. According to MarketBeat as of 05/29/2026, CL carries a consensus rating of "Moderate Buy" based on 12 buy ratings and additional hold recommendations from covering analysts, with an average target price that implies upside versus the quoted level near USD 90.

MarketBeat further indicates that analyst views reflect both the resilience of Colgate-Palmolive's cash generation and its exposure to mature but steady household and personal care categories, while also acknowledging competitive pressure from large peers in oral care and home care. This consensus backdrop helps frame the recent consolidation in the share price on the NYSE, where the stock has moved modestly lower on a single-day basis but remains materially higher than at the start of 2026.

Conclusion

Colgate-Palmolive Co is currently trading near USD 90 on the New York Stock Exchange, representing a notable advance versus its level at the start of 2026 and reflecting the market's assessment of its latest quarterly numbers and cash generation profile. The prevailing "Moderate Buy" analyst consensus outlined by MarketBeat as of 05/29/2026 highlights a broadly constructive, yet not euphoric, stance on the U.S. consumer staples group. For investors following large-cap household and personal care stocks in the United States, the current consolidation in CL offers a fresh reference point ahead of the next earnings and guidance updates.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.